Changes in the detection of human epidermal growth factor receptor 2 gene(Her-2)status for Her-2 fluorescent in situ hybridization testing  

作　　者：Ying Xu Changjun Wang Yali Xu Bo Pan Qiang Sun 

机构地区：[1]Department of Breast Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China

出　　处：《Chinese Medical Journal》2022年第7期849-850,共2页中华医学杂志（英文版）

摘　　要：Breast cancer(BC)is among the commonly diagnosed malignancies,which displaced lung cancer to become the most leading diagnosed cancer worldwide in 2020.^([1])Approximately 15%to 20%of BC patients are positive for the human epidermal growth factor receptor 2 gene(Her-2)and exhibits a high degree of malignancy.However,the definition of Her-2 positivity remains controversial and fluctuating.

关 键 词：CANCER LUNG BREAST 

分 类 号：R440[医药卫生—诊断学]